Cargando…
Relationship between Fibroblast Growth Factor 23 and Biochemical and Bone Histomorphometric Alterations in a Chronic Kidney Disease Rat Model Undergoing Parathyroidectomy
BACKGROUND: Phosphate burden in chronic kidney disease (CKD) leads to elevated serum fibroblast factor-23 (FGF-23) levels, secondary hyperparathyroidism and chronic kidney disease-mineral bone disorder (CKD-MBD). However dissociated hyperphosphatemia and low serum FGF-23 concentrations have been obs...
Autores principales: | Liao, Hung-Wei, Hung, Peir-Haur, Hsiao, Chih-Yen, Liou, Hung-Hsiang, Lin, Hsin-Shih, Huang, Tsang-Hai, Jou, I-Ming, Tsai, Kuen-Jer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506049/ https://www.ncbi.nlm.nih.gov/pubmed/26186634 http://dx.doi.org/10.1371/journal.pone.0133278 |
Ejemplares similares
-
Erythropoietin Use and the Risk of Stroke in Patients on Hemodialysis: A Retrospective Cohort Study in Taiwan
por: Hung, Peir‐Haur, et al.
Publicado: (2021) -
Erythropoietin prevents dementia in hemodialysis patients: a nationwide population-based study
por: Hung, Peir-Haur, et al.
Publicado: (2019) -
End stage renal disease is associated with development of dementia
por: Hung, Peir-Haur, et al.
Publicado: (2017) -
Parathyroidectomy Is Associated with Reduced Mortality in Hemodialysis Patients with Secondary Hyperparathyroidism
por: Ma, Tsung-Liang, et al.
Publicado: (2015) -
Parathyroidectomy Improves the Consumption of Erythropoiesis-Stimulating Agents in Hemodialysis Patients
por: Lee, Yu-Ting, et al.
Publicado: (2022)